Literature DB >> 9459247

The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat.

J H Jun1, T L Yaksh.   

Abstract

UNLABELLED: Gabapentin is an anticonvulsant that may represent a novel class of drugs, which has novel spinal antihyperalgesic activity. We sought to characterize this spinal action in a model of hyperalgesia that involves a mild thermal injury to the hind paw of the rat. Rats were prepared with chronic spinal catheters. Under brief halothane anesthesia, a thermal injury was induced by applying the left hind paw to a thermal surface (52.5 degrees C) for 45 s. This exposure results in mild erythema but no blistering. Thermal escape latency of the hind paw was determined using an underglass thermal stimulus with which response latencies of the injured and uninjured (normal) paw could be obtained. Thirty minutes after thermal injury, the response latency in all groups decreased from 10-12 s to 5-7 s. Uninjured paw withdrawal latency was unaltered. The intrathecal injection of gabapentin (30-300 microg) produced a dose-dependent reversal of the hyperalgesia but had no effect on the response latency of the normal hind paw, even at the largest doses. A similar reversal was observed after intrathecal delivery of the structural analog S(+)-3-isobutyl gamma-aminobutyric acid (GABA) (30-300 microg), but not after the largest dose of its stereoisomer R(-)-3-isobutyl GABA (300 microg). The effects of both intrathecal gabapentin and S(+)-3-isobutyl GABA were reversed by intrathecal D-serine, but not L-serine. All effects were observed at doses that had no significant effect on motor function. These observations, in conjunction with the accumulating data on binding and transmitter release, emphasize that these gabapentinoids can selectively modulate the facilitation of spinal nociceptive processing otherwise generated by persistent small afferent input generated by tissue injury. IMPLICATIONS: Gabapentin and its analog, 3-isobutyl gamma-aminobutyric acid, given spinally, produce a dose-dependent, D-serine-sensitive reversal of the thermal hyperalgesia evoked by mild thermal injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459247     DOI: 10.1097/00000539-199802000-00025

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  19 in total

Review 1.  Gabapentin: a viewpoint by Ian Gilron.

Authors:  Ian Gilron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Perioperative Multimodal Analgesia Reduces Opioid Use Following Skin Grafting in Nonintubated Burn Patients.

Authors:  Richard Lennertz; Haley Zimmerman; Timothy McCormick; Scott Hetzel; Lee Faucher; Angela Gibson
Journal:  J Burn Care Res       Date:  2020-11-30       Impact factor: 1.845

Review 3.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  James E Frampton; Rachel H Foster
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation.

Authors:  H J Park; K Sandor; J McQueen; S A Woller; C I Svensson; M Corr; T L Yaksh
Journal:  Eur J Pain       Date:  2015-10-30       Impact factor: 3.931

6.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans.

Authors:  G D Iannetti; L Zambreanu; R G Wise; T J Buchanan; J P Huggins; T S Smart; W Vennart; I Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 7.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Pregabalin: in the treatment of painful diabetic peripheral neuropathy.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Spinal p38 mitogen-activated protein kinase mediates allodynia induced by first-degree burn in the rat.

Authors:  Linda Sorkin; Camilla I Svensson; Toni L Jones-Cordero; Michael P Hefferan; W Marie Campana
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

Review 10.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  Kate McKeage; Susan J Keam
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.